Topic: Thomson Reuters Corporation
LONDON (Reuters) - Benlysta, the first new treatment for lupus in half a century, was approved for use in Europe, the drug's discoverer Human Genome Sciences and partner GlaxoSmithKline said on Thursday.The drug, which combats lupus -- a disease that causes the ...
